Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.
Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis.
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
Intertwining extracellular nucleotides and their receptors with Ca2+ in determining adult neural stem cell survival, proliferation and final fate.
Paraparetic Guillain-Barré syndrome: Non-demyelinating reversible conduction failure restricted to the lower limbs.
Neurologic indications for therapeutic plasma exchange: 2011 update.
Increased expression of Tbet in CD4(+) T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS.
Altering the course of disease in multiple sclerosis: many large steps forward.
Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
Importance of early treatment initiation in the clinical course of multiple sclerosis.
Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
TRAIL gene expression analysis in multiple sclerosis patients.
Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion.
Olfactory dysfunction in Multiple Sclerosis: A scoping review of the literature.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Engineering three dimensional micro nerve tissue using postnatal stem cells from human dental apical papilla.
Considerations in the development of generic disease therapies for multiple sclerosis.
How human IgGs against DNA recognize oligonucleotides and DNA.
Spinal Cord in Multiple Sclerosis: Magnetic Resonance Imaging Features and Differential Diagnosis.
"Immunometabolism and autoimmunity".
Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.
Antiglutamatergic therapy for multiple sclerosis?
Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.
Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Pages
« first
‹ previous
…
692
693
694
695
696
697
698
699
700
…
next ›
last »